CorMedix Inc.
- Last sale
- Nov 2, 2026 · -5.53%
- Market cap
- $427.59M
- 79.48M shares
- Filings
- 1,024
Q3 2026+617.0% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026+256.3% FY25 yoy
- $427.59M
- 6.7×
- 1.0×
- 0.9×
- 72.00%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $311,709,000 | reported | |
| FY 2024 | 2024-12-31 | $43,472,000 | reported | |
| FY 2022 | 2022-12-31 | $65,408 | reported | |
| FY 2021 | 2021-12-31 | $190,936 | reported | |
| FY 2020 | 2020-12-31 | $239,231 | reported | |
| FY 2019 | 2019-12-31 | $283,266 | reported | |
| FY 2018 | 2018-12-31 | $429,797 | reported | |
| FY 2017 | 2017-12-31 | $329,327 | reported | |
| FY 2016 | 2016-12-31 | $224,105 | reported | |
| FY 2015 | 2015-12-31 | $210,130 | reported | |
| FY 2014 | 2014-12-31 | $189,274 | reported | |
| FY 2013 | 2013-12-31 | $2,001 | reported |
Segments
LineFY2021ShareChange
United States$68.56M99%+40.1%
US———
Total$68.95M
Pharmaceutical preparations
CorMedix Inc. is the 66th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
MNKDMannkind Corp$349.0M22.2%1.7%$1.3B
CRMDCorMedix Inc. (this company)$311.7M617.0%52.3%$427.6M
EOLSEvolus, Inc.$297.2M11.6%17.4%$475.2MIRWDIronwood Pharmaceuticals Inc$296.2M15.7%8.1%$801.3MRIGLRigel Pharmaceuticals Inc$294.3M64.1%124.7%$855.8MXERSXeris Biopharma Holdings, Inc.$291.8M43.7%0.2%$3.0BAUPHAurinia Pharmaceuticals Inc.$283.1M20.4%101.5%$2.2BHROWHarrow, Inc.$272.3M36.4%1.9%$1.1BVREOFVireo Growth Inc.$268.8M170.4%25.3%$379.7MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
CorMedix Inc. · CIK 1410098 · Engraved from SEC EDGAR